Skip to main content
Clinical Trials/NCT02816918
NCT02816918CompletedPhase 1

Extraluminal Use of the Bronchial Blocker of Univent Tube During Adult One-lung Ventilation

The First Hospital of Qinhuangdao1 site in 1 country40 target enrollmentStarted: July 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
time for positioning

Study Overview

Brief Summary

intends to evaluate the feasibility and security issues of univent bronchial blockers outside the single lumen endotracheal tube for one- lung ventilation in left thoracic surgery patients.

Detailed Description

One-lung ventilation is desirable for Several clinical procedures, such as thoracic,pulmonary, and cardiac surgery to facilitate lung exposure for these surgical procedures by collapsing the lung and most commonly used device is the double-lumen tube (DLT) for this surgical procedures.Bronchial blockers (BBs), such as univent tube with an bronchial Blocker, has more advantages than the double-lumen tube: no need exchange tube when mechanical ventilation is required postoperative, easier insertion,less postoperative sore throat (ST) and hoarseness. However, BBs requires more time for placement and more difficult to position, especially patients undergoing left-side thoracic surgery. So, this study intends to evaluate the feasibility and security issues of univent bronchial blockers outside the single lumen endotracheal tube for one- lung ventilation in left thoracic surgery patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •sixty patients undergoing left thoracic surgery
  • •ASA classifications of I-II, modified Mallampati classification of 1 or 2, requiring general anesthesia were included.

Exclusion Criteria

  • •age younger than 18 yr or older than 70 yr
  • •BMI>30 kg/m2
  • •with upper respiratory tract infection,asthma
  • •Abnormalities of the heart, brain, liver, lung, kidney and coagulation functions

Arms & Interventions

Extraluminal use of Univent Blocker

Experimental

Patients assigned to the Extraluminal use of Univent Blocker group were first inserted Univent bronchial Blocker into the glottis via direct laryngoscopy then advanced the Blocker to the target bronchus until slight resistance was encountered.A conventional tracheal tube with appropriate size was intubated via direct laryngoscopy into the appropriate depth, inflating the tracheal tube cuff, and fixing the tube firmly at the patient's mouth with cloth tape .

So the Univent Blocker Extraluminal of the endotracheal tube,then the fibreoptic bronchoscopy was inserted into the tracheal tube and guided bronchial blocker cuff to the target main bronchus under direct vision

Intervention: Extraluminal use of Univent bronchial Blocker (Device)

Innerluminal use of Univent Blocker

Experimental

Patients in Innerluminal use of Univent Blocker group: When the endotracheal tube had been intubated via direct laryngoscopy, the bronchial blocker was advanced Innerluminal of the endotracheal tube and directed into the right or left mainstem bronchus, then the fibreoptic bronchoscopy was inserted into the tracheal tube. After further pushing and twisting, the bronchial blocker tube will move into the mainstem bronchus under direct vision by FOB.the tracheal tube cuff is inflated with the tube being fixed firmly at the patient's mouth with cloth tape

Intervention: Innerluminal use Univent bronchial Blocker (Device)

Outcomes

Primary Outcomes

time for positioning

Time Frame: 15 min

Secondary Outcomes

  • frequency of fiberoptic(10 min)
  • frequency of malpositions(5 min)

Investigators

Sponsor
The First Hospital of Qinhuangdao
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Extraluminal Use of the Bronchial Blocker... | Clinical Trial